these problems. this is brewing for a big fight over the next couple of weeks with the fda and this particular drug manufacturer. there is another study from glaxosmithkline that funded just out today which they are pushing back heavily against the latest studies. the question being raised that this has been known since 2007 at least in a couple of the studies, and the fwhuns in the journal of the medical association. why is the drug still on the market? that s a good question. back in 2007 when the safety concerns started to get raised there was a vote. whether or not to pull this particular drug from the market. and at that point it came one vote shy of actually pulling it. there s also this black box warning saying people who are at risk of the problems should not be taking the medication. they basically said the drug manufacturers said we need to do more safety studies. the studies will be completed in 2014. now we are hearing look, that s too long and too confusing. within t